Physician profile
Vidya Pai
NPI 1639402340
$721.82
in general payments reported to CMS, 2019-2025
10 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Sleep Medicine (Pediatrics) provider received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.82 · 2021: $11.49 · 2023: $443 · 2024: $91.68 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $356.68 | 2023 | Remede System |
| Jazz Pharmaceuticals INC. | $157.16 | 2024-2025 | |
| Harmony Biosciences LLC | $46.23 | 2023 | Wakix |
| Axsome Therapeutics, INC. | $41.69 | 2024 | Sunosi |
| Itamar Medical INC | $33.27 | 2024-2025 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $20.25 | 2023 | |
| Inspire Medical Systems, INC. | $19.71 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $18.82 | 2019 | |
| Lilly USA, LLC | $16.52 | 2025 | Mounjaro, Zepbound |
| Eisai INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidya Pai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.